Zacks Research Has Pessimistic Outlook of AGIO Q1 Earnings
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Agios Pharmaceuticals in a research note issued on Thursday, March 6th. Zacks Research analyst A. Chakraborty now forecasts that the biopharmaceutical company will earn ($1.81) per share for the quarter, down from their […]
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Agios Pharmaceuticals in a research note issued on Thursday, March 6th. Zacks Research analyst A. Chakraborty now forecasts that the biopharmaceutical company will earn ($1.81) per share for the quarter, down from their […]
